Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin in McArdle Disease
NCT02432768Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Apr 2015
- Primary completion
- Apr 2018
- Modality
- SLNs, Nanostructured Lipid Carriers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triheptanoin in Glycogen storage disease type 5 (GSD5), sponsored by Rigshospitalet. Started Apr 2015; status: completed.
02
Drugs
triheptanoin
03
Conditions
Glycogen storage disease type 5 (GSD5)
Beyond the preview
Go deeper on NCT02432768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432768.